{"pmid":32368495,"pmcid":"PMC7184249","title":"Co-infection with SARS-CoV-2 and influenza A virus.","text":["Co-infection with SARS-CoV-2 and influenza A virus.","Coronavirus Disease 2019 (COVID-19) infection, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is spreading globally and poses a major public health threat. We reported a case of influenza A virus and SARS-CoV-2 co-infection. As the number of COVID-19 cases increase, it will be necessary to comprehensively evaluate imaging and other clinical findings as well as consider co-infection with other respiratory viruses.","IDCases","Azekawa, Shuhei","Namkoong, Ho","Mitamura, Keiko","Kawaoka, Yoshihiro","Saito, Fumitake","32368495"],"abstract":["Coronavirus Disease 2019 (COVID-19) infection, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is spreading globally and poses a major public health threat. We reported a case of influenza A virus and SARS-CoV-2 co-infection. As the number of COVID-19 cases increase, it will be necessary to comprehensively evaluate imaging and other clinical findings as well as consider co-infection with other respiratory viruses."],"journal":"IDCases","authors":["Azekawa, Shuhei","Namkoong, Ho","Mitamura, Keiko","Kawaoka, Yoshihiro","Saito, Fumitake"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32368495","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.idcr.2020.e00775","keywords":["covid-19","co-infection","influenza","sars-cov-2"],"topics":["Case Report"],"weight":1,"_version_":1666138496120651776,"score":9.490897,"similar":[{"pmid":32160148,"title":"Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China.","text":["Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China.","We report co-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A virus in a patient with pneumonia in China. The case highlights possible co-detection of known respiratory viruses. We noted low sensitivity of upper respiratory specimens for SARS-CoV-2, which could further complicate recognition of the full extent of disease.","Emerg Infect Dis","Wu, Xiaojing","Cai, Ying","Huang, Xu","Yu, Xin","Zhao, Li","Wang, Fan","Li, Quanguo","Gu, Sichao","Xu, Teng","Li, Yongjun","Lu, Binghuai","Zhan, Qingyuan","32160148"],"abstract":["We report co-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A virus in a patient with pneumonia in China. The case highlights possible co-detection of known respiratory viruses. We noted low sensitivity of upper respiratory specimens for SARS-CoV-2, which could further complicate recognition of the full extent of disease."],"journal":"Emerg Infect Dis","authors":["Wu, Xiaojing","Cai, Ying","Huang, Xu","Yu, Xin","Zhao, Li","Wang, Fan","Li, Quanguo","Gu, Sichao","Xu, Teng","Li, Yongjun","Lu, Binghuai","Zhan, Qingyuan"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32160148","source":"PubMed","week":"202011|Mar 09 - Mar 15","doi":"10.3201/eid2606.200299","keywords":["2019 novel coronavirus disease","covid-19","china","sars-cov-2","co-detection","co-infection","influenza","influenza a","pneumonia","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138492667691009,"score":214.44357},{"pmid":32399452,"pmcid":"PMC7213830","title":"Co-infection with Influenza A and COVID-19.","text":["Co-infection with Influenza A and COVID-19.","COVID-19, also called severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2), originated in Wuhan, China. It has caused significant morbidity and mortality worldwide and has been declared a global pandemic by the WHO. Influenza occurs mainly during the winter, with the burden of disease determined by several factors, including the effectiveness of the vaccine that season, the characteristics of the circulating viruses, and how long the season lasts. We describe the case of a 66-year-old woman who was diagnosed with influenza A and COVID-19 co-infection. LEARNING POINTS: COVID-19 can co-occur with other viral infections.Some of these co-infections have active treatments, while supportive treatment is the mainstay of treatment for others.","Eur J Case Rep Intern Med","Konala, Venu Madhav","Adapa, Sreedhar","Gayam, Vijay","Naramala, Srikanth","Daggubati, Subba Rao","Kammari, Chetan Brahma","Chenna, Avantika","32399452"],"abstract":["COVID-19, also called severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2), originated in Wuhan, China. It has caused significant morbidity and mortality worldwide and has been declared a global pandemic by the WHO. Influenza occurs mainly during the winter, with the burden of disease determined by several factors, including the effectiveness of the vaccine that season, the characteristics of the circulating viruses, and how long the season lasts. We describe the case of a 66-year-old woman who was diagnosed with influenza A and COVID-19 co-infection. LEARNING POINTS: COVID-19 can co-occur with other viral infections.Some of these co-infections have active treatments, while supportive treatment is the mainstay of treatment for others."],"journal":"Eur J Case Rep Intern Med","authors":["Konala, Venu Madhav","Adapa, Sreedhar","Gayam, Vijay","Naramala, Srikanth","Daggubati, Subba Rao","Kammari, Chetan Brahma","Chenna, Avantika"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399452","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.12890/2020_001656","keywords":["covid-19","coronavirus","acute respiratory distress syndrome","influenza"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666865855053430784,"score":171.63637},{"pmid":32470606,"pmcid":"PMC7250072","title":"Clinical Characteristics of Critically Ill Patients Co-infected with SARS-CoV-2 and the Influenza Virus in Wuhan, China.","text":["Clinical Characteristics of Critically Ill Patients Co-infected with SARS-CoV-2 and the Influenza Virus in Wuhan, China.","OBJECTIVE: To delineate the clinical characteristics of critically ill COVID-19 patients co-infected with influenza. METHODS: In this study, we included adult patients with laboratory-confirmed COVID-19 form Tongji Hospital (Wuhan, China), with or without influenza, and compared their clinical characteristics. RESULTS: Among 93 patients, 44 died and 49 were discharged. Forty-four (47.3%) were infected with influenza virus A and 2 (2.2%) with influenza virus B. Twenty-two (50.0%) of the non-survivors and 24 (49.0%) of the survivors were infected with the influenza virus. Critically ill COVID-19 patients with influenza were more prone to cardiac injury than those without influenza. For the laboratory indicators at admission, white blood cell counts, neutrophil counts, levels of tumor necrosis factor-alpha, D-dimer value, and proportion of elevated creatinine were higher in non-survivors with influenza than in those without influenza. CONCLUSION: The results showed a high proportion of COVID-19 patients were co-infected with influenza in Tongji Hospital, with no significant difference in the proportion of co-infection between survivors and non-survivors. The critically ill COVID-19 patients with influenza exhibited more severe inflammation and organ injury, indicating that co-infection with the influenza virus may induce an earlier and more frequently occurring cytokine storm.","Int J Infect Dis","Ma, Simin","Lai, Xiaoquan","Chen, Zhe","Tu, Shenghao","Qin, Kai","32470606"],"abstract":["OBJECTIVE: To delineate the clinical characteristics of critically ill COVID-19 patients co-infected with influenza. METHODS: In this study, we included adult patients with laboratory-confirmed COVID-19 form Tongji Hospital (Wuhan, China), with or without influenza, and compared their clinical characteristics. RESULTS: Among 93 patients, 44 died and 49 were discharged. Forty-four (47.3%) were infected with influenza virus A and 2 (2.2%) with influenza virus B. Twenty-two (50.0%) of the non-survivors and 24 (49.0%) of the survivors were infected with the influenza virus. Critically ill COVID-19 patients with influenza were more prone to cardiac injury than those without influenza. For the laboratory indicators at admission, white blood cell counts, neutrophil counts, levels of tumor necrosis factor-alpha, D-dimer value, and proportion of elevated creatinine were higher in non-survivors with influenza than in those without influenza. CONCLUSION: The results showed a high proportion of COVID-19 patients were co-infected with influenza in Tongji Hospital, with no significant difference in the proportion of co-infection between survivors and non-survivors. The critically ill COVID-19 patients with influenza exhibited more severe inflammation and organ injury, indicating that co-infection with the influenza virus may induce an earlier and more frequently occurring cytokine storm."],"journal":"Int J Infect Dis","authors":["Ma, Simin","Lai, Xiaoquan","Chen, Zhe","Tu, Shenghao","Qin, Kai"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470606","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.ijid.2020.05.068","keywords":["covid-19","co-infection","cytokine storm","influenza","organ injury"],"locations":["Wuhan","China","Tongji Hospital","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Creatinine"],"topics":["Diagnosis"],"weight":1,"_version_":1668420887210098688,"score":166.1469},{"pmid":32271596,"title":"Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran.","text":["Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran.","BACKGROUND: In late December 2019, a viral pneumonia known as coronavirus disease 2019 (COVID-19) originated from China and spread very rapidly in the world. Since then, COVID-19 has become a global concern and health problem. METHODS: We present four patients in this study, selected from among patients who presented with pneumonia symptoms and were suspicious for COVID-19. They were referred to the intended centers for COVID-19 diagnosis and management of Shiraz University of Medical Sciences in southern Iran. Two nasopharyngeal and oropharyngeal throat swab samples were collected from each patient and tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using real-time reverse-transcriptase- polymerase-chain-reaction (RT-PCR). The samples were also tested for influenza viruses and the complete respiratory panel. RESULTS: In the present report, four patients were diagnosed in the starting days of COVID-19 disease in our center in southern Iran with co-infection of SARS-CoV-2 and influenza A virus. CONCLUSION: This co-infection of COVID-19 and influenza A highlights the importance of considering SARS-CoV-2 PCR assay regardless of other positive findings for other pathogens in the primary test during the epidemic.","Arch Iran Med","Khodamoradi, Zohre","Moghadami, Mohsen","Lotfi, Mehrzad","32271596"],"abstract":["BACKGROUND: In late December 2019, a viral pneumonia known as coronavirus disease 2019 (COVID-19) originated from China and spread very rapidly in the world. Since then, COVID-19 has become a global concern and health problem. METHODS: We present four patients in this study, selected from among patients who presented with pneumonia symptoms and were suspicious for COVID-19. They were referred to the intended centers for COVID-19 diagnosis and management of Shiraz University of Medical Sciences in southern Iran. Two nasopharyngeal and oropharyngeal throat swab samples were collected from each patient and tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using real-time reverse-transcriptase- polymerase-chain-reaction (RT-PCR). The samples were also tested for influenza viruses and the complete respiratory panel. RESULTS: In the present report, four patients were diagnosed in the starting days of COVID-19 disease in our center in southern Iran with co-infection of SARS-CoV-2 and influenza A virus. CONCLUSION: This co-infection of COVID-19 and influenza A highlights the importance of considering SARS-CoV-2 PCR assay regardless of other positive findings for other pathogens in the primary test during the epidemic."],"journal":"Arch Iran Med","authors":["Khodamoradi, Zohre","Moghadami, Mohsen","Lotfi, Mehrzad"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271596","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.34172/aim.2020.04","keywords":["covid-19","coinfection","coronavirus disease 2019","influenza","severe acute respiratory syndrome coronavirus 2"],"locations":["China","Iran","Iran","Iran"],"countries":["China","Iran, Islamic Republic of"],"countries_codes":["CHN|China","IRN|Iran, Islamic Republic of"],"topics":["Case Report"],"weight":1,"_version_":1666138491740749824,"score":165.48041},{"pmid":32475878,"title":"The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses.","text":["The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses.","Coronavirus disease 2019 (COVID-19) is a severe infectious disease of the respiratory tract caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2, and has a high mortality rate. The disease emerged from Wuhan, China, in late 2019, and spread to Japan, including Hokkaido, in January 2020. In February 2020, three children were diagnosed with COVID-19 in Furano, Hokkaido, Japan. During this period, influenza and human metapneumovirus infections were prevalent among children in the Furano region. Two of the three cases experienced co-infection with other respiratory viruses, including influenza virus A or human metapneumovirus. To the authors' knowledge, the cases described in the present report were the first pediatric patients with COVID-19 in Japan. In children with COVID-19, the possibility of co-infection with other respiratory pathogens should be considered.","Jpn J Infect Dis","Kakuya, Fujio","Okubo, Hitoshi","Fujiyasu, Hiroaki","Wakabayashi, Iori","Syouji, Masayo","Kinebuchi, Takahiro","32475878"],"abstract":["Coronavirus disease 2019 (COVID-19) is a severe infectious disease of the respiratory tract caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2, and has a high mortality rate. The disease emerged from Wuhan, China, in late 2019, and spread to Japan, including Hokkaido, in January 2020. In February 2020, three children were diagnosed with COVID-19 in Furano, Hokkaido, Japan. During this period, influenza and human metapneumovirus infections were prevalent among children in the Furano region. Two of the three cases experienced co-infection with other respiratory viruses, including influenza virus A or human metapneumovirus. To the authors' knowledge, the cases described in the present report were the first pediatric patients with COVID-19 in Japan. In children with COVID-19, the possibility of co-infection with other respiratory pathogens should be considered."],"journal":"Jpn J Infect Dis","authors":["Kakuya, Fujio","Okubo, Hitoshi","Fujiyasu, Hiroaki","Wakabayashi, Iori","Syouji, Masayo","Kinebuchi, Takahiro"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32475878","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.7883/yoken.JJID.2020.181","keywords":["covid-19","sars-cov-2","children","co-infection","respiratory pathogens"],"locations":["Wuhan","China","Japan","Hokkaido","Furano","Hokkaido","Japan","Furano","Japan","Japan"],"countries":["Japan","China"],"countries_codes":["JPN|Japan","CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1668437835071356928,"score":163.59178}]}